Advertisement
Advertisement
RANI
Rani Therapeutics Holdings, Inc. Class A Common Stock
0.77
USDSponsored
+0.01
+1.59%
Jun 24, 16:00 UTC -4
Closed
After-Market
0.76
-0.01
-0.91%
RANI Earnings Reports
Positive Surprise Ratio
RANI beat 16 of 20 last estimates.
80%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Rani Therapeutics Holdings, Inc. Class A Common Stock earnings per share and revenue
On May 15, 2026, RANI reported earnings of -0.04 USD per share (EPS) for Q1 26, beating the estimate of -0.04 USD, resulting in a 12.85% surprise. Revenue reached 1.71 million, compared to an expected 510.00 thousand, with a 234.90% difference. The market reacted with a +5.71% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Rani Therapeutics Holdings, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Rani Therapeutics Holdings, Inc. Class A Common Stock reported EPS of -$0.04, beating estimates by 12.85%, and revenue of $1.71M, 234.9% above expectations.
How did the market react to Rani Therapeutics Holdings, Inc. Class A Common Stock's Q1 2026 earnings?
The stock price moved up 5.71%, changed from $1.05 before the earnings release to $1.11 the day after.
When is Rani Therapeutics Holdings, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Rani Therapeutics Holdings, Inc. Class A Common Stock's next earnings report?
Based on --
analysts, Rani Therapeutics Holdings, Inc. Class A Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement